Outcomes after pelvic fascia-sparing robot-assisted radical prostatectomy vs. standard robot-assisted radical prostatectomy
Sarah Kodres-O’Brien , Christopher Dall , Tamir Sholklapper , Keith Kowalczyk
Mini-invasive Surgery ›› 2025, Vol. 9 ›› Issue (1) : 23
Outcomes after pelvic fascia-sparing robot-assisted radical prostatectomy vs. standard robot-assisted radical prostatectomy
Urinary incontinence immediately following robotic-assisted laparoscopic radical prostatectomy can significantly impact quality of life. Pelvic fascia-sparing robotic-assisted radical prostatectomy (PFS-RARP) was first described in 2010 to improve urinary functional outcomes via further preservation of anterior pelvic fascial structures. In this article, we summarize the anatomic basis, origin, and outcomes of PFS-RARP compared to standard RARP (S-RARP), highlighting potential advantages in urinary continence and ongoing debate over oncologic efficacy.
Robot-assisted prostatectomy / Retzius-sparing prostatectomy / pelvic fascia-sparing prostatectomy / urinary continence / sexual function / outcomes / prostate cancer
| [1] |
AUANews. Westerman ME. Robotic prostatectomy: a game-changer in prostate cancer treatment. 2024. Available from: https://auanews.net/issues/articles/2024/february-2024/robotics-robotic-prostatectomy-a-game-changer-in-prostate-cancer-treatment. [Last accessed on 11 Jul 2025] |
| [2] |
Lane A, Metcalfe C, Young GJ, et al; ProtecT Study group. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life. BJU Int. 2016;118:869-79. PMCID:PMC5113698 |
| [3] |
|
| [4] |
|
| [5] |
De Carlo F, Celestino F, Verri C, Masedu F, Liberati E, Di Stasi SM. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: surgical, oncological, and functional outcomes: a systematic review.Urol Int2014;93:373-83 |
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
Chipman JJ, Sanda MG, Dunn RL, et al; PROST-QA Consortium. Measuring and predicting prostate cancer related quality of life changes using EPIC for clinical practice. J Urol. 2014;191:638-45. PMCID:PMC5006995 |
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
Mount Sinai. Hood technique enables early return to continence following RARP. 2020. Available from: https://reports.mountsinai.org/article/hood-technique-enables-early-return-to-continence-following-rarp. [Last accessed on 11 Jul 2025] |
| [43] |
ClinicalTrials.gov. Clinical trial of approaches to prostate cancer surgery (PARTIAL). 2025. Available from: https://www.clinicaltrials.gov/ct2/show/NCT05155501. [Last accessed on 11 Jul 2025] |
/
| 〈 |
|
〉 |